Among 90 screened lncRNAs, the authors found significantly higher levels of nuclear-enriched abundant transcript 1 (NEAT1) and brain cytoplasmic (BC200) in AD subjects than the control group with sensitivity of 72% and 60%, and specificity of 84% and 91%, respectively, evaluated by ROC curve analysis. Here, NEAT1 is linked to Alzheimer disease.